Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13 Article DOI:
Cite this article as: Chie, WC., Yang, CH., Hsu, C. et al. Qual Life Res (2004) 13: 257. doi:10.1023/B:QURE.0000015295.74812.06 Abstract
The purpose of this study was to test the validity and reliability of the Taiwan Chinese translation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30, version 3) and Quality of Life Questionnaire Lung Cancer-13 (QLQ-LC13) questionnaires. Consecutively 51 patients with lung cancer undergoing active chemotherapy and 48 such patients undergoing regular follow-up completed the questionnaires. The intraclass correlation between test and retest ranged from 0.46 to 0.85 for the QLQ-C30 and was 0.76 for dyspnea for the QLQ-LC13. The κ coefficients between test and retest ranged from 0.51 to 0.73 for single items of the QLQ-C30 and 0.49–0.68 for five of the nine items in the QLQ-LC13. The Cronbach's α coefficients were ≥ 0.70 for all scales of the two questionnaires apart from that of cognitive functioning. The correlation coefficients between indices measuring similar dimensions of the EORTC QLQ-C30 and the SF-36 questionnaires ranged from 0.43 to 0.73, and that between the dyspnea scales of the two EORTC questionnaires was 0.70. Patients in the follow-up group revealed higher scores of global status/quality of life, and lower scores of nausea/vomiting, as also physical functioning. The questionnaires could also detect expected adverse effects of radiotherapy, cisplatin, and paclitaxel.
EORTC QLQ-C30 EORTC QLQ-LC13 Lung cancer Quality of life References
Department of Health, the Executive Yuan, Cancer Registry Annual Report, Republic of China, 1998. Web-site of Department of Health: www.doh.gov.tw, 2002.
Division of Cancer Research, National Health Research Institutes and Taiwan Cooperative Organization of Cancer. Consensus of Diagnosis and Treatment of Lung Cancer. Taipei: National Health Research Institutes, 1998.
Montazeri A, Gills CR, McEwen J. Quality of life in patients with lung cancer. Chest 1998; 113: 467-481.
Aaronson NK, Ahmedzai A, Berman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
Hjerstad MJ, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 1995; 13: 1249-1254.
Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50: 441-450.
Kobayashi K, Takeda F, Teramukai S, et al. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 1998; 34: 810-815.
Bergman B, Aaronson NK, Ahmedzai S, et al. The EORTC QLQ-C13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 1994; 30A: 635-642.
EORTC quality of Life Study Group. Questionnaire for the Department of Obstetric and gynecology, Hong Kong University (Chinese Translation of the EORTC QLQ-C30 version 2.0). Brussels: Quality of Life Unit, EORTC Data Center, 1997.
Zhao H, Kanada K. Translation and validation of the Standard Chinese version of the EORTC QLQ-C30. Qual Life Res 2000; 9: 139-137.
Cull A, Sprangers M, Bjordal K, et al. EORTC Quality of Life Study Group Translation Procedure. Brussels: EORTC Quality of Life Study Group, 1998.
New England Medical Center Hospital. IQOLA SF-36 Taiwan Standard Version 1.0. Boston: The Health Institute, New England Medical Center, 1996.
Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.
Chie WC, Huang CS, Chen JH, Chang KJ. Measurement of the quality of life during different clinical phases of breast cancer. J Formos Med Assoc 1999; 98: 254-260.
Fuh JL, Wang SJ, Lu SR, Juang KD, Lee SJ. Psychometric evaluation of a Chinese (Taiwanese) Version of the SF-36 Health Survey amongst middle-aged women from a rural community. Qual Life Res 2000; 9: 675-683.
Chiu HC, Chern JY, Shi HY, Chen SH, Chang JK. Physical functioning and health-related quality of life: Before and after total hip replacement. Kaohsiung J Med Sci 2000; 16: 285-292.
Wang SJ, Fuh JL, Lu SR, Juang KD. Quality of life differs among headache diagnoses: Analysis of SF-36 survey in 901 headache patients. Pain 2001; 89: 285-292.
Fayers P, Aaronson N, Bjordal K, Curran D, Groenvold M. EORTC QLQ-C30 Scoring Manual. 2nd ed. Brussels: EORTC Quality of Life Study Group, 1999.
Chie WC, Hong RL, Lai CC, Ting LL, Hsu MM. Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35. Qual Life Res 2003; 12: 93-98.
Streiner DL, Norman GR. Reliability. In Streiner DL, Norman GR (eds). Health Measurement Scales. A Practical Guide to Their Development and Use. Oxford: Oxford Medical, 1994; 79-96.
Fayers P, Weeden S, Curran D. EORTC QLQ-C30 Reference Values. Brussels: EORTC Quality of Life Study Group, 1998.
Google Scholar Copyright information
© Kluwer Academic Publishers 2004